Age, years
|
< 0.001
|
18–25
|
–
| | | |
26–35
|
−11.1 (−16.2; − 5.89)
|
< 0.001
|
−11.6 (−17.0; −6.3)
|
< 0.001
|
36–45
|
−24.0 (−30.1; − 17.92)
|
< 0.001
|
−25.1(−31.6; − 18.7)
|
< 0.001
|
> 45
|
−33.9 (− 41.8; − 25.93)
|
< 0.001
|
−35.5 (− 43.9; − 27.1)
|
< 0.001
|
Sex, Female
|
5.1 (0.3; 9.8)
|
0.04
|
−4.6 (− 9.6; 0.4)
|
0.07
|
WHO Stage
|
I
|
–
|
–
|
–
|
–
|
II
|
0.1 (−5.8; 6.0)
|
0.98
|
–
|
–
|
III
|
1.4 (−4.3; 7.2)
|
0.62
|
–
|
–
|
IV
|
− 1.7 (− 10.7; 7.1)
|
0.69
|
–
|
–
|
Weight, kg
|
−0.3 (− 0.5; 0.01)
|
0.06
|
− 0.2 (− 0.5; 0.1)
|
0.17
|
Fat Free mass, Kg
|
− 0.2 (− 0.5; 0.2)
|
0.32
|
–
|
–
|
Fat mass, kg
|
− 0.3 (− 0.8; 0.1)
|
0.15
|
–
|
–
|
Height, m
|
− 0.2 (− 0.5; 0.06)
|
0.13
|
–
|
–
|
Body mass index, kg/m2
|
− 0.4 (− 1.2; 0.5)
|
0.42
|
–
|
–
|
Fat mass index, kg/m2
|
− 0.5 (− 1.6; 0.6)
|
0.34
|
–
|
–
|
Fat free mass index, kg/m2
|
− 0.03 (−1.4; 1.4)
|
0.96
|
–
|
–
|
Hypertension, Yes
|
−15.7 (−32.8; 1.3)
|
0.07
|
−6.6 (−22.0; 8.7)
|
0.39
|
C-reactive protein, mg/L
|
−0.1 (− 0.2; 0.01)
|
0.08
|
− 0.1 (− 0.2; − 0.02)
|
0.02
|
CD4 count, cells/ul
|
−0.002 (− 0.02; 0.02)
|
0.88
|
–
|
–
|
On tuberculosis treatment, Yes
|
6.1 (−1.3; 13.5)
|
0.11
|
–
|
–
|
Hepatitis B surface antigen positive1, Yes
|
1.8 (−10.0; 13.7)
|
0.76
|
–
|
–
|
Hepatitis C virus antibody Positive2, Yes
|
18.8 (−10.8; 48.3)
|
0.21
|
–
|
–
|
Viral load, log (copies+ 1/mL)
|
0.8 (−1.4; 3.2)
|
0.45
|
–
|
–
|